CryoTherapeutics
CryoTherapeutics develops a patented system consisting of a console and an intracoronary balloon catheter designed for use by interventional cardiologists. The technology delivers a cooling agent to treat vulnerable atherosclerotic plaques at temperatures between -10°C and -20°C. This procedure aims to stabilize plaques by reducing inflammation and increasing fibrous cap thickness to prevent heart attacks.
Healthtech
Medical Devices
Cardiovascular
Funding summary
- Total raised
- €29.3M
- Funding rounds
- 3
Investors in CryoTherapeutics
Investors on record for CryoTherapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like CryoTherapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors